Coenzyme Q10, Folic Acid and Red Yeast Rice: study protocols
5 study groups took Coenzyme Q10 together with Folic Acid and Red Yeast Rice. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Coenzyme Q10
5 study groups in 5 studies say how much Coenzyme Q10 participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mg to 2.5 mg, 80% of 5 study groups.
| Daily dose | Study groups |
|---|---|
| 1 mg to 2.5 mg | 4 |
| 2.5 mg to 5 mg | 0 |
| 5 mg to 10 mg | 0 |
| 10 mg to 25 mg | 0 |
| 25 mg to 50 mg | 1 |
Dose per serving from research: Folic Acid
5 study groups in 5 studies say how much Folic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mcg to 250 mcg, 100% of 5 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mcg to 250 mcg | 5 |
Dose per serving from research: Red Yeast Rice
5 study groups in 5 studies say how much Red Yeast Rice participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mg to 250 mg, 100% of 5 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mg to 250 mg | 5 |
Commonly used together
5 of 5 study groups took Coenzyme Q10, Folic Acid and Red Yeast Rice with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Berberine | 4 |
| Policosanol | 4 |
| Astaxanthin | 3 |
5 study groups
| Study | |||||
|---|---|---|---|---|---|
| Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial 2015 · Combination A · Adults aged 18–70 with hypercholesterolemia not requiring statins or statin-intolerant | 2 mg | 200 mcg | 200 mg | 4 weeks | 23 |
| Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q(10) on lipid levels: a randomized, double-blind, placebo controlled study 2017 · Armolipid Plus (AM) · Adults aged 18–75, both sexes, with mild-to-moderate hypercholesterolemia | 2 mg | 200 mcg | 200 mg | 4 weeks | — |
| Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial 2014 · Intervention (Armolipid Plus/AP) · Men and women older than 18 years with mild-moderate hypercholesterolemia and elevated LDL-c, candidates for lifestyle intervention without hypolipemic drug treatment | 2 mg | 200 mcg | 200 mg | 12 weeks | 51 |
| Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial 2017 · Active nutraceutical · Adults aged 25–75 with moderately elevated cholesterol and metabolic syndrome, in primary cardiovascular prevention | 50 mg | 110 mcg | 200 mg | 6 weeks | 30 |
| Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial 2019 · Nutraceutical B · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded. | 2 mg | 200 mcg | 200 mg | 6 weeks | 23 |